“Dr. Red: Tizanidine 4mg Tablets Recall - Shaved Tablets Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/36070-dr-red-tizanidine-4mg-tablets-recall-shaved-tablets-hazard. Based on FDA recall #D-0750-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0750-2021%22&limit=1).
The FDA announced on July 19, 2021, that Dr. Reddy's Laboratories, Inc. voluntarily recalled Tizanidine HCl Tablets, USP 4 mg, because some tablets are shaved. The recall affects 37,560 bottles distributed nationwide.
How to tell if you have it
Brand: Dr. Reddy's
Product: Tizanidine HCl Tablets, USP 4 mg
Packaging: 150-count bottles
NDC: 55111-180-15
Lot #: T2000471
Expiration date: 09/2023
Manufacturer: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA
The hazard
The recall was issued because some tablets are shaved, which constitutes a failed tablet specification. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Dr. Reddy's Laboratories, Inc. has had 85 other recalls on record since April 9, 2012. Other recent recalls of similar products include Dr. Reddy's Varenicline Tablets Recall (Nov. 11, 2025), Dr. Reddy's Succinylcholine Chloride Injection Recall (Sept. 26, 2025), and Dr. Reddy's Omeprazole Capsules Recall (June 30, 2025). Other recent recalls of similar products include Fresenius Kabi Lidocaine HCl Injection Recall (July 16, 2026), Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall (Nov. 21, 2025), and Shoolin Pharma Chem Sildenafil Recall (Aug. 3, 2026).
How to tell if you have this one
Check for the lot number T2000471 on the bottle. The product was manufactured in Srikakulam, India, and expires September 2023.
Brand
Dr. Reddy's
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number T2000471 on the bottle label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0750-2021 (July 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0750-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.